Inventor · Los Angeles, CA, US

Sherie L. Morrison

25Patents
11h-index
34Co-inventors
75Inventor score

Filing activity: Jul 16, 1993 → Sep 14, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US5807715A Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin Chemistry; Metallurgy 564 Expired
US5977307A Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins Chemistry; Metallurgy 193 Expired
US5672683A Transferrin neuropharmaceutical agent fusion protein Chemistry; Metallurgy 150 Expired
US6284536A Modified immunoglobin molecules and methods for use thereof Chemistry; Metallurgy 116 Expired
US6218149A Antibodies having modified carbohydrate content and methods of preparation and use Chemistry; Metallurgy 111 Expired
US9139634B2 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities Chemistry; Metallurgy 68 Active
US8258263B2 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities Chemistry; Metallurgy 31 Active
US6300104A Secretory immunoglobulin produced by single cells and methods for making and using same Emerging Cross-Sectional Technologies 26 Expired
US6861572B1 Production of proteins in eggs Human Necessities 23 Expired
US7736652B2 Antibody fusion proteins: effective adjuvants of protein vaccination Chemistry; Metallurgy 15 Expired
US9803021B2 CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities Chemistry; Metallurgy 13 Active
US8563692B2 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities Chemistry; Metallurgy 10 Active
US6043345A IgE isoforms and methods of use Chemistry; Metallurgy 9 Expired
US9534033B2 Targeted interferons demonstrating potent apoptotic and anti-tumor activities Chemistry; Metallurgy 5 Active
US10182984B2 Targeted interferons demonstrate potent apoptotic and anti-tumor activities Chemistry; Metallurgy 3 Active
US10093745B2 Anti-CSPG4 fusions with interferon for the treatment of malignancy Chemistry; Metallurgy 3 Active
US6475749B1 Rh hybrid antibody Physics 3 Expired
US10822427B2 Anti-CSPG4 fusions with interferon for the treatment of malignancy Chemistry; Metallurgy 2 Active
US11136353B2 Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof Chemistry; Metallurgy 2 Active
US10975158B2 CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities Chemistry; Metallurgy 2 Active
US11795198B2 Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof Chemistry; Metallurgy 0 Active
US12415843B2 Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer Chemistry; Metallurgy 0 Active
US9611313B2 Antibody-endostatin fusion protein and its variants Physics 0 Active
US7238784B2 Rh antibody Physics 0 Expired
US12162958B2 Fusion protein composition(s) comprising masked type i interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.